メリーランド州におけるCOPDの臨床試験
メリーランド州内の拠点で、COPDに関する16件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
被験者募集中第4相
40歳〜85歳 · 全性別 · 2026/09/22更新 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Baltimore
- Research Site, Baltimore
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Johns Hopkins University, Baltimore
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Baltimore
- Research Site, Potomac
- Research Site, Rosedale
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Baltimore
- Research Site, Columbia
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Oxon Hill
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966STRIVE Post-Market Registry Study
- University of Maryland, Baltimore
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Maryland, Baltimore
- Johns Hopkins, Baltimore
- Tidal Health, Salisbury
被験者募集中第3相
40歳以上 · 全性別 · 2026/07/31更新 · NCT06376994SPIROMICS Study of Early COPD Progression (SOURCE)
- Johns Hopkins Bayview Medical Center, Baltimore
被験者募集中観察研究健康なボランティア歓迎
30歳〜55歳 · 全性別 · 2026/06/03更新 · NCT05033990Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Rockville
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214Trial to Determine Effective Aspirin Dose in COPD
- Johns Hopkins Bayview Medical Center, Baltimore
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/03/16更新 · NCT05265299OMEGA - Dietary Intervention - COPD Trial
- Johns Hopkins Bayview Campus, Baltimore
被験者募集中
40歳以上 · 全性別 · 2026/03/16更新 · NCT05297279Effectiveness of the WearME System for COPD Severity and Respiratory Function
- Johns Hopkins, Baltimore
- TidalHealth, Salisbury
被験者募集中観察研究
21歳〜100歳 · 全性別 · 2025/09/09更新 · NCT06751537Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Ascension St. Agnes Hospital, Baltimore
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Maryland - Baltimore, Baltimore
被験者募集中
30歳以上 · 全性別 · 2025/02/06更新 · NCT05204888ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。